Press releases

A common goal, to improve the lives of patients

Zambon and Vectans Pharma laboratories have entered into a partnership to ensure the marketing of Virpax®, Lauriad® Aciclovir 50mg, in France.

Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®

Exclusive agreement with Berlin Chemie for Sitavig® in Eastern Europe and the CIS region

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Nomination of François Boutignon as Chief Innovation and Technology Officer

China approves commercialization for Oravig®

Exclusive licensing agreement with m8 Pharmaceuticals

Image Medias
230 Bureaux de la colline
92213 Saint-Cloud